Why bone metastases resist treatment: New method identifies immune cells shielding tumors

Researchers at Baylor College of Medicine and collaborating institutions have developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary cause of death for most patients with solid tumors. The method not only revealed cellular features shared by metastatic niches of multiple cancer models, but also uncovered an unexpected driver of immune suppression in bone metastasis. The study appears in the journal Cell.